| NKT cells: what's in a name? | Nature Reviews Immunology | 2004 | 931 |
| Cytokines in cancer immunity and immunotherapy | Immunological Reviews | 2004 | 306 |
| TRAIL and its receptors as targets for cancer therapy | Cancer Science | 2004 | 221 |
| Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells | Journal of Experimental Medicine | 2004 | 187 |
| Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy | Journal of Experimental Medicine | 2004 | 180 |
| NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy | Journal of Immunology | 2004 | 167 |
| NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer | Journal of Experimental Medicine | 2004 | 145 |
| Histone-Deacetylase Inhibitors for the Treatment of Cancer | Cell Cycle | 2004 | 110 |
| Granzyme M mediates a novel form of perforin-dependent cell death | Journal of Biological Chemistry | 2004 | 96 |
| Mutational analysis of P-glycoprotein: suppression of caspase activation in the absence of ATP-dependent drug efflux | Cell Death and Differentiation | 2004 | 87 |
| Alpha-galactosylceramide: potential immunomodulatory activity and future application | Current Medicinal Chemistry | 2004 | 69 |
| Discordant regulation of granzyme H and granzyme B expression in human lymphocytes | Journal of Biological Chemistry | 2004 | 67 |
| Gene-engineered T cells as a superior adjuvant therapy for metastatic cancer | Journal of Immunology | 2004 | 65 |
| The functional basis for hemophagocytic lymphohistiocytosis in a patient with co-inherited missense mutations in the perforin (PFN1) gene | Journal of Experimental Medicine | 2004 | 63 |
| A functional role for CD28 costimulation in tumor recognition by single-chain receptor-modified T cells | Cancer Gene Therapy | 2004 | 51 |
| Regulation of antitumour immunity by CD1d-restricted NKT cells | Immunology and Cell Biology | 2004 | 49 |
| Immunotherapy of cancer using systemically delivered gene-modified human T lymphocytes | Human Gene Therapy | 2004 | 43 |
| Cutting edge: novel priming of tumor-specific immunity by NKG2D-triggered NK cell-mediated tumor rejection and Th1-independent CD4+ T cell pathway | Journal of Immunology | 2004 | 42 |
| Antigen-induced tolerance by intrathymic modulation of self-recognizing inhibitory receptors | Nature Immunology | 2004 | 40 |
| Histone-deacetylase inhibitors for the treatment of cancer | Cell Cycle | 2004 | 40 |
| Cytotoxic activity of the lymphocyte toxin granzyme B | Microbes and Infection | 2004 | 39 |
| Parallels and distinctions between T and NKT cell development in the thymus | Immunology and Cell Biology | 2004 | 35 |
| Immunology. The elusive NKT cell antigen--is the search over? | Science | 2004 | 30 |
| Assaying cytochrome C translocation during apoptosis | Methods in Molecular Biology | 2004 | 29 |
| Subsite specificities of granzyme M: a study of inhibitors and newly synthesized thiobenzyl ester substrates | Archives of Biochemistry and Biophysics | 2004 | 17 |
